International Company For Medical Industries S.A.E. (EGX:FCMD)
Egypt · Delayed Price · Currency is EGP 7.05
0.00 (0.00%)
At close: Sep 8, 2026
EGX:FCMD Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 67.62 | 57.71 | 34.77 | 11.97 | 1.07 | 2.19 |
Revenue Growth | 22.39% | 65.99% | 190.46% | 1013.95% | -50.92% | -64.61% |
Cost of Revenue | 53.03 | 38.94 | 27.01 | 9.37 | 1.33 | 1.88 |
Gross Profit | 14.59 | 18.78 | 7.76 | 2.6 | -0.26 | 0.31 |
Selling, General & Admin | 11.81 | 9.75 | 7.74 | 2.88 | 0.2 | 0.33 |
Other Operating Expenses | 3.5 | 3.5 | - | - | - | - |
Operating Expenses | 17.69 | 19.11 | 11.13 | 2.89 | 0.23 | 0.36 |
Operating Income | -3.1 | -0.34 | -3.37 | -0.29 | -0.49 | -0.04 |
Interest Expense | -0.61 | -0.73 | -1.12 | -0.02 | -0.11 | -0.07 |
Interest & Investment Income | - | - | 0.03 | 1.24 | - | - |
Currency Exchange Gain (Loss) | 0.36 | 0.36 | - | - | - | - |
Other Non Operating Income (Expenses) | 8.03 | -14.35 | 0 | -0.06 | -0 | 0.13 |
EBT Excluding Unusual Items | 4.68 | -15.05 | -4.46 | 0.87 | -0.6 | 0.02 |
Gain (Loss) on Sale of Investments | -0.97 | - | -6.15 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 12.35 | - | 0.55 | - |
Legal Settlements | -1.25 | -1.25 | - | - | - | - |
Pretax Income | 2.46 | -16.3 | 1.74 | 0.87 | -0.05 | 0.02 |
Income Tax Expense | -2.74 | - | 0.05 | -0.05 | 0.04 | -0.02 |
Earnings From Continuing Operations | 5.21 | -16.3 | 1.69 | 0.92 | -0.09 | 0.03 |
Minority Interest in Earnings | -2.36 | -3.43 | -0.18 | - | - | - |
Net Income | 2.84 | -19.73 | 1.51 | 0.92 | -0.09 | 0.03 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.01 |
Net Income to Common | 2.84 | -19.73 | 1.51 | 0.92 | -0.09 | 0.03 |
Net Income Growth | - | - | 64.88% | - | - | -27.61% |
Shares Outstanding (Basic) | 57 | 58 | 58 | 58 | 24 | 24 |
Shares Outstanding (Diluted) | 57 | 58 | 58 | 58 | 24 | 24 |
Shares Change | -1.09% | - | - | 138.41% | - | - |
EPS (Basic) | 0.05 | -0.34 | 0.03 | 0.02 | -0.00 | 0.00 |
EPS (Diluted) | 0.05 | -0.34 | 0.03 | 0.02 | -0.00 | 0.00 |
EPS Growth | - | - | 64.87% | - | - | -27.59% |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | 2.01 | 10.99 | 15.76 | -21.74 | -1.08 | -1.35 |
Free Cash Flow Per Share | 0.04 | 0.19 | 0.27 | -0.38 | -0.04 | -0.06 |
Gross Margin | 21.58% | 32.53% | 22.32% | 21.73% | -24.04% | 14.34% |
Operating Margin | -4.58% | -0.58% | -9.70% | -2.39% | -45.28% | -1.96% |
Profit Margin | 4.21% | -34.19% | 4.36% | 7.67% | -8.50% | 1.26% |
Free Cash Flow Margin | 2.97% | 19.04% | 45.33% | -181.58% | -100.73% | -61.70% |
EBITDA | -0.89 | 1.14 | 0.02 | 0.54 | 0.34 | 0.79 |
EBITDA Margin | -1.32% | 1.97% | 0.05% | 4.50% | 31.56% | 36.05% |
D&A For EBITDA | 2.2 | 1.47 | 3.39 | 0.83 | 0.83 | 0.83 |
EBIT | -3.1 | -0.34 | -3.37 | -0.29 | -0.49 | -0.04 |
EBIT Margin | -4.58% | -0.58% | -9.70% | -2.39% | -45.28% | -1.96% |
Effective Tax Rate | - | - | 2.61% | - | - | - |